Magali Rouyer

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Radical Prostatectomy

Top Venues

Expert review of clinical pharmacology

British journal of clinical pharmacology

BMC medical research methodology

Cancer innovation

This page only lists publications with an associated author ORCID identifier.

Publications

Roméo Baulain, Jérémy Jové, Dunia Sakr, Marine Gross-Goupil, Magali Rouyer, Marius Puel, Patrick Blin, Cécile Droz-Perroteau, Régis Lassalle, Nicolas H Thurin
Clustering of prostate cancer healthcare pathways in the French National Healthcare database. Cancer innovation 2 (1) (2023)
Nicolas H Thurin, Magali Rouyer, Jérémy Jové, Marine Gross-Goupil, Thibaud Haaser, Xavier Rébillard, Michel Soulié, Gérard de Pouvourville, Camille Capone, Marie-Laure Bazil, Fatiha Messaoudi, Stéphanie Lamarque, Emmanuelle Bignon, Cécile Droz-Perroteau, Nicholas Moore, Patrick Blin
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database. Expert review of clinical pharmacology 15 (9) (2022)
Nicolas H Thurin, Pauline Bosco-Levy, Patrick Blin, Magali Rouyer, Jérémy Jové, Stéphanie Lamarque, Séverine Lignot, Régis Lassalle, Abdelilah Abouelfath, Emmanuelle Bignon, Pauline Diez, Marine Gross-Goupil, Michel Soulié, Mathieu Roumiguié, Sylvestre Le Moulec, Marc Debouverie, Bruno Brochet, Francis Guillemin, Céline Louapre, Elisabeth Maillart, Olivier Heinzlef, Nicholas Moore, Cécile Droz-Perroteau
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data. BMC medical research methodology 21 (1) (2021)
Magali Rouyer, Eric François, Antonio Sa Cunha, Alain Monnereau, Emmanuelle Bignon, Jérémy Jové, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore, Pernelle Noize, Annie Fourrier-Réglat, Denis Smith
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort. British journal of clinical pharmacology 87 (3) (2020)